Form 4: Nuvalent CFO Executes Pre-Arranged Stock Sale Following Option Exercise
Insider Transaction Report
Nuvalent, Inc.'s Chief Financial Officer, Alexandra Balcom, sold 20,000 shares of Class A Common Stock for a weighted average price of $80.02 after exercising stock options at $18.93, as part of a Rule 10b5-1 trading plan.
Summary
- Alexandra Balcom, Nuvalent, Inc.'s Chief Financial Officer, engaged in transactions involving the company's Class A Common Stock.
- On June 27, 2025, Ms. Balcom acquired 20,000 shares of Class A Common Stock by exercising stock options at a price of $18.93 per share.
- Concurrently, on June 27, 2025, she disposed of 20,000 shares of Class A Common Stock at a weighted average price of $80.02 per share, with individual sales ranging from $80.00 to $80.13.
- These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024.
- Following these transactions, Ms. Balcom's direct beneficial ownership of Class A Common Stock decreased from 81,734 shares to 61,734 shares.
- The stock options exercised were part of a grant where 25% vested on January 4, 2023, with the remainder vesting over three years in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a pre-arranged Rule 10b5-1 plan mitigates concerns about opportunistic selling. Furthermore, the CFO realized a substantial profit from the transaction, which is a positive outcome for the individual and reflects the value creation for option holders.
Positives
- The Chief Financial Officer realized a significant profit from the exercise of stock options and subsequent sale of shares, indicating the value of the company's equity compensation program.
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which demonstrates a systematic and pre-planned approach to managing personal finances, reducing concerns about opportunistic insider selling.
Negatives
- The sale of 20,000 shares by a key executive, even under a pre-arranged plan, results in a reduction of their direct equity ownership in the company.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The sale by a CFO might be interpreted by some as a slight reduction in management's direct equity alignment, though the pre-planned nature mitigates this concern. The profitable exercise of options highlights the value of equity compensation for executives.
Key Dates
| Date | Description |
|---|---|
| 01/04/2023 | Vesting date for 25% of the stock options exercised. |
| 12/12/2024 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 06/27/2025 | Date of stock option exercise and subsequent sale of Class A Common Stock. |
| 07/01/2025 | Signature date of the filing by attorney-in-fact. |
| 01/04/2032 | Expiration date of the stock options. |
Keywords
Nuvalent Inc, NUVL, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, Chief Financial Officer, Alexandra Balcom, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.